Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis

Indian Journal of Hematology and Blood Transfusion

Volumn 28, Issue 1, 2012, Pages 1-6

  Hon, Gloudina M ^a   Hassan, Mogamat S ^a   Van Rensburg, Susan J ^b   Abel, Stefan ^c   Erasmus, Rajiv T ^d   Matsha, Tandi ^a  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Fatty acids; Membrane fluidity; Multiple sclerosis; Phospholipids

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ADULT; ARTICLE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENZYME ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LIPID MEMBRANE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 84858998888     PISSN: 09714502     EISSN: 09740449     Source Type: Journal    
DOI: 10.1007/s12288-011-0087-x     Document Type: Article

References (26)

1. Adams CWM (1977) Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 33:15-20
2. Adibhatla RM, Hatcher JF (2007) Role of lipids in brain injury and diseases. Future Lipidol 2:403-422 (Pubitemid 47250149)
3. Harbige LS, Sharief MK (2007) Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr 98:S46-S53 (Pubitemid 47543477)
4. Hon GM, Hassan M, Van Rensburg SJ et al (2009) Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis. Br J Nutr 102:1334-1340
5. Caret RL, Denniston KJ, Topping JJ (1997) Lipids and their functions in biochemical systems. In: Wheatley CH (ed) Principles and applications of inorganic, organic and biological chemistry, 2nd edn. McGraw-Hill, Boston, pp 379-407
6. Horrobin DF (1999) The phospholipid concept of psychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia. In: Peet M, Glen I, Horrobin DF (eds) Phospholipid spectrum disorder in psychiatry. Marius Press, Lancashire, pp 3-16
7. Zwaal RFA, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121-1132 (Pubitemid 27079974)
8. Barenholz Y, Thompson TE (1999) Sphingomyelin: biophysical aspects. Chem Phys Lipids 102:29-34 (Pubitemid 29438656)
9. Calder PC (2007) Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 77:327-335
10. De Pablo MA, De Cienfuegos GÁ (2000) Modulatory effects of dietary lipids on immune system functions. Immunol Cell Biol 78:31-39 (Pubitemid 30090987)
11. Chia LS, Thompson JE, MoscarelloMA(1984) Alteration of lipidphase behavior in multiple sclerosis myelin revealed by wide-angle X-ray diffraction. Proc Natl Acad Sci USA 81:1871-1874 (Pubitemid 14149567)
12. Williams EE (1998) Membrane lipids: what membrane physical properties are conserved during physiochemically-induced membrane restructuring? Am Zool 38:280-290
13. Allen HG, Allen JC, Boyd LC et al (2006) Determination of membrane lipid differences in insulin resistant diabetes mellitus type 2 in whites and blacks. Nutrition 22:1096-1102 (Pubitemid 44692444)
14. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
15. Itaya K, Ui M (1966) A new micromethod for the colorimetric determination of inorganic phosphate. Clin Chim Acta 14:361-366
16. Smuts CM, Weich HFH, Weight MJ et al (1994) Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease. Coron Artery Dis 5:331-338 (Pubitemid 24151527)
17. Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
18. Van Jaarsveld PJ, Smuts CM, Tichelaar HY et al (2000) Effect of palm oil on plasma lipoprotein concentrations and plasma lowdensity lipoprotein composition in non-human primates. Int J Food Sci Nutr 51:S21-S30 (Pubitemid 32040786)
19. Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. And its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19:1350-1356
20. Kaushal V, Barnes LD (1986) Effect of zwitterionic buffers on measurement of small masses of protein with bicinchoninic acid. Anal Biochem 157:291-294
21. Voet D, Voet JG (1995) Lipids and membranes. In: Voet D, Voet JG (eds) Biochemistry. John Wiley and Sons Inc, New York, pp 277-329
22. BarenholzY(2002) Cholesterol and other membrane active sterols: from membrane evolution to "rafts". Prog Lipid Res 41:1-5
23. Giovannoni G, Miller DH, Losseff NA et al (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol 248:487-495 (Pubitemid 32663880)
24. Sellner J, Greeve I, Mattle HP (2008) Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis. Mult Scler 14:981-984
25. Giovannoni G, Thorpe JW, Kidd D et al (1996) Soluble E-selectin in multiple sclerosis: raised concentrations in patients with primary progressive disease. J Neurol Neurosurg Psychiatry 60:20-26 (Pubitemid 26012262)
26. Volanakis JE, Narkates AJ (1981) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol 126:1820-1825 (Pubitemid 11120965)